DORIS COOLS, M.D.

 

Education:

  • Maria Assumpta Lyceum Brussels, Latin-Sciences
  • Doctor in Medecine: 1992-1995 Limburgs Universitair Centrum LUC: with distinction
  • Doctor in Medecine: 1995-1999: Katholieke Universiteit Leuven KUL: with distinction

Specialisation in Opthalmology:

  • 2000-2001: University Hospital, Leuven, Prof. Spileers
  • 2001-2002: 6 months Cliniques Universitaires St.-Luc, Brussels, Prof. De Potter; 6 months University Hospital, Leuven, Prof. Spileers
  • 2002-2003: 6 months University Hospital, Leuven, Prof. Spileers; 6 months St-Jan Hospital Brussels, Dr. Vryghem
  • 2003-2004: University Hospital, Leuven, Prof. Spileers

Fellowship Medical retina:
Oogziekenhuis Rotterdam: with Dr. Baarsma and Dr. Martinez

Scientific Achievement:

  • 2000: Winner First Price FRO: Belgian Fund of Research in Opthalmology:
    Prognostic value of chromosomal abnormalities in primary uveal melanoma: A molecular cytogenetic prospective study on fresh biopsies and a retrospective study on frozen and paraffin sections.
  • 1999: Laureate FRO: Belgian Fund for Research in Opthalmology:
    The prognostic value of chromosomal abnormalities in primary uveal melanoma: a molecular cytogenetic study on biopsies and needle aspiration biopsies

Research and publications:

  • Lectures
    • Cools D., Vryghem J.
      Opthalmologica Belgica, November 2003, Brussels;
      Clinical Results, contrast sensitivity and wavefront aberrations comparing the Pharmacia
      Tecnis Z9000 and the Bausch and Lomb Akreos Adapt IOLS
    • Cools D., Van Ginderdeuren R. Debiec-Rychter M., Spileers W.
      Opthalmologica Belgica, November 2001, Brussels
      Preliminary results of FRO project 2000: The prognostic value of chromosomal abnormalities in primary uveal melanoma.
    • Cools D., Eneman B., Spileers W.
      Opthalmologica Belgica, December 2000, Brussels
      The clinical use of multifocal ERG in multiple ocular pathologies Preliminary results of FRO project 1999: the prognostic value of chromosomal abnormalities in primary uveal melnoma: a molecular cytogenetic study on biopsies and needle aspiration biopsies.
    • Cools D., Van Ginderdeuren R., Debiec-Rychter M., Spileers W.
      EVER, European Association for Vision and Eye Research: OOG-Group-meeting, October 2000, Palma
      Chromosomal abnormalities in uveal melanoma: A retrospective and prospective study on frozen and fresh tissue.
    • Cools D., Van Ginderdeuren R., Debiec-Rychter M., Spileers W.
      EVER, European Association for Vision and Eye Research: Joint meeting FRO - Belgian Fund for Research in Opthalmology, October 2000, Palma
      The prognostic value of chromosomal abnormalities in primary uveal melanoma: a molecular cytogenetic prospective study on fresh biopsies and retrospective study on frozen and paraffin sections.
    • Cools D., Van Ginderdeuren R. Debiec-Rychter M., Spileers W.
      EVER 1999, European Association for Vision and Eye Research Joint Meeting FRO - Belgian Fund for Research in Opthalmology, October 1999, Palma
      The prognostic value of chromosomal abnormalities in primary uveal melanoma: a molecular cytogenetic study on biopsies and needle aspiration biopsies.
    • Cools D., Spileers W., Eneman B., Maris K., Van Malderen L.
      Opthalmologica Belica, November 2001, Brussels
      Isoluminant colour visual evoked potentials in nomal and colour-deficient subjects.
  • Article
    • Cools D., Debiec-Rychter M., Parys-Van Ginderdeuren R., Hagemeijer-Hausman A., Van den Oord J., Spileers W.
      Preliminary results of the FRO Project: chromosomal abnormalities in primary uveal melanoma
    • Bull. Soc. Belge Opthalmol 278, 67-70, 2000

Knowledge of languages:

  • Dutch: native
  • French: fluent
  • English: fluent
  • German: moderate

Brussels Eye Doctors is ISO 9001 :2008 certified since june 2006.

This certification guarantees:
Patient oriented approach
Professionalism
Quality Management